nodes	percent_of_prediction	percent_of_DWPC	metapath
Zoledronate—ABCC1—Irinotecan—colon cancer	0.217	0.416	CbGbCtD
Zoledronate—ABCC1—Vincristine—colon cancer	0.19	0.364	CbGbCtD
Zoledronate—ABCC1—Methotrexate—colon cancer	0.115	0.22	CbGbCtD
Zoledronate—CA14—Reversible hydration of carbon dioxide—CA7—colon cancer	0.0517	0.329	CbGpPWpGaD
Zoledronate—CA12—Reversible hydration of carbon dioxide—CA7—colon cancer	0.0436	0.277	CbGpPWpGaD
Zoledronate—CA2—Reversible hydration of carbon dioxide—CA7—colon cancer	0.0333	0.212	CbGpPWpGaD
Zoledronate—GGPS1—renal system—colon cancer	0.00657	0.0867	CbGeAlD
Zoledronate—GGPS1—lymphoid tissue—colon cancer	0.00546	0.072	CbGeAlD
Zoledronate—GGPS1—bone marrow—colon cancer	0.00497	0.0655	CbGeAlD
Zoledronate—GGPS1—vagina—colon cancer	0.00476	0.0628	CbGeAlD
Zoledronate—GGPS1—liver—colon cancer	0.00402	0.053	CbGeAlD
Zoledronate—CA2—gall bladder—colon cancer	0.00328	0.0432	CbGeAlD
Zoledronate—FDPS—smooth muscle tissue—colon cancer	0.00315	0.0415	CbGeAlD
Zoledronate—GGPS1—lymph node—colon cancer	0.00308	0.0406	CbGeAlD
Zoledronate—CA12—renal system—colon cancer	0.00306	0.0404	CbGeAlD
Zoledronate—FDPS—renal system—colon cancer	0.00303	0.04	CbGeAlD
Zoledronate—FDPS—lymphoid tissue—colon cancer	0.00252	0.0332	CbGeAlD
Zoledronate—CA12—digestive system—colon cancer	0.00251	0.0331	CbGeAlD
Zoledronate—FDPS—digestive system—colon cancer	0.00249	0.0328	CbGeAlD
Zoledronate—CA14—liver—colon cancer	0.0024	0.0317	CbGeAlD
Zoledronate—Risedronate—PTGS2—colon cancer	0.00236	0.529	CrCbGaD
Zoledronate—FDPS—bone marrow—colon cancer	0.00229	0.0302	CbGeAlD
Zoledronate—FDPS—vagina—colon cancer	0.0022	0.0289	CbGeAlD
Zoledronate—GGPS1—Metabolism—CA7—colon cancer	0.00215	0.0137	CbGpPWpGaD
Zoledronate—Clodronate—PTGS2—colon cancer	0.00211	0.471	CrCbGaD
Zoledronate—CA2—embryo—colon cancer	0.00208	0.0274	CbGeAlD
Zoledronate—FDPS—liver—colon cancer	0.00185	0.0244	CbGeAlD
Zoledronate—CA2—epithelium—colon cancer	0.0017	0.0224	CbGeAlD
Zoledronate—ABCC1—Irinotecan Pathway—APC—colon cancer	0.00165	0.0105	CbGpPWpGaD
Zoledronate—CA2—smooth muscle tissue—colon cancer	0.00163	0.0215	CbGeAlD
Zoledronate—CA2—renal system—colon cancer	0.00157	0.0207	CbGeAlD
Zoledronate—FDPS—lymph node—colon cancer	0.00142	0.0187	CbGeAlD
Zoledronate—CA2—lymphoid tissue—colon cancer	0.00131	0.0172	CbGeAlD
Zoledronate—GGPS1—Metabolism—CHST5—colon cancer	0.0013	0.00829	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—ODC1—colon cancer	0.0013	0.00829	CbGpPWpGaD
Zoledronate—CA2—digestive system—colon cancer	0.00129	0.017	CbGeAlD
Zoledronate—ABCC1—vagina—colon cancer	0.00127	0.0168	CbGeAlD
Zoledronate—FDPS—SREBP signalling—PPARG—colon cancer	0.00124	0.0079	CbGpPWpGaD
Zoledronate—CA2—bone marrow—colon cancer	0.00119	0.0157	CbGeAlD
Zoledronate—CA2—vagina—colon cancer	0.00114	0.015	CbGeAlD
Zoledronate—ABCC1—liver—colon cancer	0.00108	0.0142	CbGeAlD
Zoledronate—ABCC1—ABC-family proteins mediated transport—ABCB1—colon cancer	0.00107	0.00682	CbGpPWpGaD
Zoledronate—CA14—Metabolism—CA7—colon cancer	0.00105	0.00668	CbGpPWpGaD
Zoledronate—ABCC1—S1P1 pathway—PTGS2—colon cancer	0.000979	0.00622	CbGpPWpGaD
Zoledronate—CA2—liver—colon cancer	0.000961	0.0127	CbGeAlD
Zoledronate—FDPS—Metabolism—CA7—colon cancer	0.000919	0.00584	CbGpPWpGaD
Zoledronate—CA12—Metabolism—CA7—colon cancer	0.000886	0.00563	CbGpPWpGaD
Zoledronate—ABCC1—lymph node—colon cancer	0.000825	0.0109	CbGeAlD
Zoledronate—ABCC1—S1P1 pathway—VEGFA—colon cancer	0.000771	0.0049	CbGpPWpGaD
Zoledronate—CA2—lymph node—colon cancer	0.000737	0.00972	CbGeAlD
Zoledronate—CA2—Metabolism—CA7—colon cancer	0.000677	0.0043	CbGpPWpGaD
Zoledronate—CA14—Metabolism—CHST5—colon cancer	0.000637	0.00405	CbGpPWpGaD
Zoledronate—CA14—Metabolism—ODC1—colon cancer	0.000637	0.00405	CbGpPWpGaD
Zoledronate—FDPS—SREBP signalling—PIK3CA—colon cancer	0.000601	0.00382	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—ODC1—colon cancer	0.000557	0.00354	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—CHST5—colon cancer	0.000557	0.00354	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	0.000538	0.00342	CbGpPWpGaD
Zoledronate—CA12—Metabolism—ODC1—colon cancer	0.000537	0.00341	CbGpPWpGaD
Zoledronate—CA12—Metabolism—CHST5—colon cancer	0.000537	0.00341	CbGpPWpGaD
Zoledronate—FDPS—SREBP signalling—AKT1—colon cancer	0.000491	0.00312	CbGpPWpGaD
Zoledronate—ABCC1—Arachidonic acid metabolism—PTGS2—colon cancer	0.000451	0.00287	CbGpPWpGaD
Zoledronate—Oedema—Vincristine—colon cancer	0.00044	0.00183	CcSEcCtD
Zoledronate—Stomatitis—Capecitabine—colon cancer	0.000438	0.00182	CcSEcCtD
Zoledronate—Infection—Vincristine—colon cancer	0.000437	0.00181	CcSEcCtD
Zoledronate—Conjunctivitis—Capecitabine—colon cancer	0.000437	0.00181	CcSEcCtD
Zoledronate—Urinary tract infection—Capecitabine—colon cancer	0.000437	0.00181	CcSEcCtD
Zoledronate—Convulsion—Fluorouracil—colon cancer	0.000436	0.00181	CcSEcCtD
Zoledronate—Osteoarthritis—Methotrexate—colon cancer	0.000434	0.0018	CcSEcCtD
Zoledronate—Confusional state—Irinotecan—colon cancer	0.000432	0.00179	CcSEcCtD
Zoledronate—Nervous system disorder—Vincristine—colon cancer	0.000431	0.00179	CcSEcCtD
Zoledronate—Thrombocytopenia—Vincristine—colon cancer	0.000431	0.00179	CcSEcCtD
Zoledronate—Haematuria—Capecitabine—colon cancer	0.000429	0.00178	CcSEcCtD
Zoledronate—Oedema—Irinotecan—colon cancer	0.000428	0.00178	CcSEcCtD
Zoledronate—Anaphylactic shock—Irinotecan—colon cancer	0.000428	0.00178	CcSEcCtD
Zoledronate—Chest pain—Fluorouracil—colon cancer	0.000428	0.00178	CcSEcCtD
Zoledronate—Myalgia—Fluorouracil—colon cancer	0.000428	0.00178	CcSEcCtD
Zoledronate—Infection—Irinotecan—colon cancer	0.000426	0.00177	CcSEcCtD
Zoledronate—Hyperhidrosis—Vincristine—colon cancer	0.000425	0.00177	CcSEcCtD
Zoledronate—GGPS1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	0.000424	0.00269	CbGpPWpGaD
Zoledronate—Discomfort—Fluorouracil—colon cancer	0.000423	0.00176	CcSEcCtD
Zoledronate—Shock—Irinotecan—colon cancer	0.000422	0.00175	CcSEcCtD
Zoledronate—Nervous system disorder—Irinotecan—colon cancer	0.00042	0.00174	CcSEcCtD
Zoledronate—Agranulocytosis—Capecitabine—colon cancer	0.00042	0.00174	CcSEcCtD
Zoledronate—Thrombocytopenia—Irinotecan—colon cancer	0.00042	0.00174	CcSEcCtD
Zoledronate—Anorexia—Vincristine—colon cancer	0.000419	0.00174	CcSEcCtD
Zoledronate—Hyperhidrosis—Irinotecan—colon cancer	0.000414	0.00172	CcSEcCtD
Zoledronate—Confusional state—Fluorouracil—colon cancer	0.000414	0.00172	CcSEcCtD
Zoledronate—Hypotension—Vincristine—colon cancer	0.000411	0.00171	CcSEcCtD
Zoledronate—Bradycardia—Capecitabine—colon cancer	0.000411	0.00171	CcSEcCtD
Zoledronate—CA2—Metabolism—ODC1—colon cancer	0.00041	0.00261	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CHST5—colon cancer	0.00041	0.00261	CbGpPWpGaD
Zoledronate—Oedema—Fluorouracil—colon cancer	0.00041	0.0017	CcSEcCtD
Zoledronate—Anaphylactic shock—Fluorouracil—colon cancer	0.00041	0.0017	CcSEcCtD
Zoledronate—Anorexia—Irinotecan—colon cancer	0.000408	0.0017	CcSEcCtD
Zoledronate—Infection—Fluorouracil—colon cancer	0.000408	0.00169	CcSEcCtD
Zoledronate—Nervous system disorder—Fluorouracil—colon cancer	0.000402	0.00167	CcSEcCtD
Zoledronate—Thrombocytopenia—Fluorouracil—colon cancer	0.000402	0.00167	CcSEcCtD
Zoledronate—Hypoaesthesia—Capecitabine—colon cancer	0.000402	0.00167	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Vincristine—colon cancer	0.000401	0.00166	CcSEcCtD
Zoledronate—Tachycardia—Fluorouracil—colon cancer	0.000401	0.00166	CcSEcCtD
Zoledronate—Hypotension—Irinotecan—colon cancer	0.0004	0.00166	CcSEcCtD
Zoledronate—Urinary tract disorder—Capecitabine—colon cancer	0.000399	0.00165	CcSEcCtD
Zoledronate—Insomnia—Vincristine—colon cancer	0.000398	0.00165	CcSEcCtD
Zoledronate—Oedema peripheral—Capecitabine—colon cancer	0.000398	0.00165	CcSEcCtD
Zoledronate—Connective tissue disorder—Capecitabine—colon cancer	0.000397	0.00165	CcSEcCtD
Zoledronate—Urethral disorder—Capecitabine—colon cancer	0.000396	0.00164	CcSEcCtD
Zoledronate—Paraesthesia—Vincristine—colon cancer	0.000395	0.00164	CcSEcCtD
Zoledronate—Anorexia—Fluorouracil—colon cancer	0.000391	0.00162	CcSEcCtD
Zoledronate—Insomnia—Irinotecan—colon cancer	0.000388	0.00161	CcSEcCtD
Zoledronate—Paraesthesia—Irinotecan—colon cancer	0.000385	0.0016	CcSEcCtD
Zoledronate—Hypotension—Fluorouracil—colon cancer	0.000383	0.00159	CcSEcCtD
Zoledronate—Decreased appetite—Vincristine—colon cancer	0.000382	0.00159	CcSEcCtD
Zoledronate—Dyspnoea—Irinotecan—colon cancer	0.000382	0.00159	CcSEcCtD
Zoledronate—Somnolence—Irinotecan—colon cancer	0.000381	0.00158	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Vincristine—colon cancer	0.00038	0.00158	CcSEcCtD
Zoledronate—Fatigue—Vincristine—colon cancer	0.000379	0.00157	CcSEcCtD
Zoledronate—Eye disorder—Capecitabine—colon cancer	0.000377	0.00157	CcSEcCtD
Zoledronate—Dyspepsia—Irinotecan—colon cancer	0.000377	0.00157	CcSEcCtD
Zoledronate—Pain—Vincristine—colon cancer	0.000376	0.00156	CcSEcCtD
Zoledronate—Constipation—Vincristine—colon cancer	0.000376	0.00156	CcSEcCtD
Zoledronate—Asthma—Methotrexate—colon cancer	0.000375	0.00156	CcSEcCtD
Zoledronate—Cardiac disorder—Capecitabine—colon cancer	0.000375	0.00156	CcSEcCtD
Zoledronate—Flushing—Capecitabine—colon cancer	0.000375	0.00156	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000374	0.00155	CcSEcCtD
Zoledronate—Decreased appetite—Irinotecan—colon cancer	0.000372	0.00155	CcSEcCtD
Zoledronate—Insomnia—Fluorouracil—colon cancer	0.000371	0.00154	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Irinotecan—colon cancer	0.00037	0.00154	CcSEcCtD
Zoledronate—Fatigue—Irinotecan—colon cancer	0.000369	0.00153	CcSEcCtD
Zoledronate—Paraesthesia—Fluorouracil—colon cancer	0.000369	0.00153	CcSEcCtD
Zoledronate—Constipation—Irinotecan—colon cancer	0.000366	0.00152	CcSEcCtD
Zoledronate—Pain—Irinotecan—colon cancer	0.000366	0.00152	CcSEcCtD
Zoledronate—Angiopathy—Capecitabine—colon cancer	0.000366	0.00152	CcSEcCtD
Zoledronate—Dyspnoea—Fluorouracil—colon cancer	0.000366	0.00152	CcSEcCtD
Zoledronate—Somnolence—Fluorouracil—colon cancer	0.000365	0.00151	CcSEcCtD
Zoledronate—Immune system disorder—Capecitabine—colon cancer	0.000365	0.00151	CcSEcCtD
Zoledronate—Mediastinal disorder—Capecitabine—colon cancer	0.000364	0.00151	CcSEcCtD
Zoledronate—Chills—Capecitabine—colon cancer	0.000362	0.0015	CcSEcCtD
Zoledronate—Dyspepsia—Fluorouracil—colon cancer	0.000361	0.0015	CcSEcCtD
Zoledronate—Arrhythmia—Capecitabine—colon cancer	0.000361	0.0015	CcSEcCtD
Zoledronate—Abdominal discomfort—Methotrexate—colon cancer	0.00036	0.00149	CcSEcCtD
Zoledronate—Gastrointestinal pain—Vincristine—colon cancer	0.00036	0.00149	CcSEcCtD
Zoledronate—Decreased appetite—Fluorouracil—colon cancer	0.000357	0.00148	CcSEcCtD
Zoledronate—Alopecia—Capecitabine—colon cancer	0.000357	0.00148	CcSEcCtD
Zoledronate—Pancytopenia—Methotrexate—colon cancer	0.000357	0.00148	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000354	0.00147	CcSEcCtD
Zoledronate—Mental disorder—Capecitabine—colon cancer	0.000354	0.00147	CcSEcCtD
Zoledronate—Feeling abnormal—Irinotecan—colon cancer	0.000353	0.00147	CcSEcCtD
Zoledronate—GGPS1—Metabolism of lipids and lipoproteins—EP300—colon cancer	0.000352	0.00224	CbGpPWpGaD
Zoledronate—Erythema—Capecitabine—colon cancer	0.000351	0.00146	CcSEcCtD
Zoledronate—Malnutrition—Capecitabine—colon cancer	0.000351	0.00146	CcSEcCtD
Zoledronate—Neutropenia—Methotrexate—colon cancer	0.000351	0.00146	CcSEcCtD
Zoledronate—Pain—Fluorouracil—colon cancer	0.000351	0.00146	CcSEcCtD
Zoledronate—Gastrointestinal pain—Irinotecan—colon cancer	0.00035	0.00145	CcSEcCtD
Zoledronate—Upper respiratory tract infection—Methotrexate—colon cancer	0.000349	0.00145	CcSEcCtD
Zoledronate—Abdominal pain—Vincristine—colon cancer	0.000348	0.00144	CcSEcCtD
Zoledronate—Body temperature increased—Vincristine—colon cancer	0.000348	0.00144	CcSEcCtD
Zoledronate—GGPS1—Metabolism—ABCB1—colon cancer	0.000345	0.00219	CbGpPWpGaD
Zoledronate—Dysgeusia—Capecitabine—colon cancer	0.000344	0.00143	CcSEcCtD
Zoledronate—Back pain—Capecitabine—colon cancer	0.00034	0.00141	CcSEcCtD
Zoledronate—Abdominal pain—Irinotecan—colon cancer	0.000339	0.00141	CcSEcCtD
Zoledronate—Body temperature increased—Irinotecan—colon cancer	0.000339	0.00141	CcSEcCtD
Zoledronate—GGPS1—Metabolism—TYMS—colon cancer	0.000338	0.00215	CbGpPWpGaD
Zoledronate—Feeling abnormal—Fluorouracil—colon cancer	0.000338	0.0014	CcSEcCtD
Zoledronate—Muscle spasms—Capecitabine—colon cancer	0.000338	0.0014	CcSEcCtD
Zoledronate—Infestation NOS—Methotrexate—colon cancer	0.000335	0.00139	CcSEcCtD
Zoledronate—Infestation—Methotrexate—colon cancer	0.000335	0.00139	CcSEcCtD
Zoledronate—Depression—Methotrexate—colon cancer	0.000334	0.00139	CcSEcCtD
Zoledronate—Vision blurred—Capecitabine—colon cancer	0.000331	0.00137	CcSEcCtD
Zoledronate—Tremor—Capecitabine—colon cancer	0.000329	0.00137	CcSEcCtD
Zoledronate—Renal failure—Methotrexate—colon cancer	0.000329	0.00137	CcSEcCtD
Zoledronate—ABCC1—Metabolism—CA7—colon cancer	0.000328	0.00208	CbGpPWpGaD
Zoledronate—Stomatitis—Methotrexate—colon cancer	0.000326	0.00135	CcSEcCtD
Zoledronate—Ill-defined disorder—Capecitabine—colon cancer	0.000326	0.00135	CcSEcCtD
Zoledronate—Urticaria—Fluorouracil—colon cancer	0.000326	0.00135	CcSEcCtD
Zoledronate—Conjunctivitis—Methotrexate—colon cancer	0.000325	0.00135	CcSEcCtD
Zoledronate—Anaemia—Capecitabine—colon cancer	0.000325	0.00135	CcSEcCtD
Zoledronate—Body temperature increased—Fluorouracil—colon cancer	0.000324	0.00135	CcSEcCtD
Zoledronate—Hypersensitivity—Vincristine—colon cancer	0.000324	0.00135	CcSEcCtD
Zoledronate—Haematuria—Methotrexate—colon cancer	0.000319	0.00132	CcSEcCtD
Zoledronate—Malaise—Capecitabine—colon cancer	0.000317	0.00132	CcSEcCtD
Zoledronate—Vertigo—Capecitabine—colon cancer	0.000316	0.00131	CcSEcCtD
Zoledronate—Hypersensitivity—Irinotecan—colon cancer	0.000316	0.00131	CcSEcCtD
Zoledronate—Asthenia—Vincristine—colon cancer	0.000316	0.00131	CcSEcCtD
Zoledronate—Syncope—Capecitabine—colon cancer	0.000315	0.00131	CcSEcCtD
Zoledronate—Leukopenia—Capecitabine—colon cancer	0.000315	0.00131	CcSEcCtD
Zoledronate—Agranulocytosis—Methotrexate—colon cancer	0.000312	0.0013	CcSEcCtD
Zoledronate—Palpitations—Capecitabine—colon cancer	0.000311	0.00129	CcSEcCtD
Zoledronate—Loss of consciousness—Capecitabine—colon cancer	0.000309	0.00128	CcSEcCtD
Zoledronate—Asthenia—Irinotecan—colon cancer	0.000307	0.00128	CcSEcCtD
Zoledronate—Cough—Capecitabine—colon cancer	0.000307	0.00127	CcSEcCtD
Zoledronate—Hypertension—Capecitabine—colon cancer	0.000303	0.00126	CcSEcCtD
Zoledronate—Hypersensitivity—Fluorouracil—colon cancer	0.000302	0.00126	CcSEcCtD
Zoledronate—Diarrhoea—Vincristine—colon cancer	0.000301	0.00125	CcSEcCtD
Zoledronate—Myalgia—Capecitabine—colon cancer	0.000299	0.00124	CcSEcCtD
Zoledronate—Chest pain—Capecitabine—colon cancer	0.000299	0.00124	CcSEcCtD
Zoledronate—Arthralgia—Capecitabine—colon cancer	0.000299	0.00124	CcSEcCtD
Zoledronate—Anxiety—Capecitabine—colon cancer	0.000298	0.00124	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000297	0.00123	CcSEcCtD
Zoledronate—Urinary tract disorder—Methotrexate—colon cancer	0.000297	0.00123	CcSEcCtD
Zoledronate—Discomfort—Capecitabine—colon cancer	0.000296	0.00123	CcSEcCtD
Zoledronate—Urethral disorder—Methotrexate—colon cancer	0.000295	0.00122	CcSEcCtD
Zoledronate—Diarrhoea—Irinotecan—colon cancer	0.000293	0.00122	CcSEcCtD
Zoledronate—Dry mouth—Capecitabine—colon cancer	0.000293	0.00121	CcSEcCtD
Zoledronate—Dizziness—Vincristine—colon cancer	0.000291	0.00121	CcSEcCtD
Zoledronate—Pruritus—Fluorouracil—colon cancer	0.00029	0.00121	CcSEcCtD
Zoledronate—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—colon cancer	0.00029	0.00184	CbGpPWpGaD
Zoledronate—Confusional state—Capecitabine—colon cancer	0.000289	0.0012	CcSEcCtD
Zoledronate—Oedema—Capecitabine—colon cancer	0.000287	0.00119	CcSEcCtD
Zoledronate—Infection—Capecitabine—colon cancer	0.000285	0.00118	CcSEcCtD
Zoledronate—Dizziness—Irinotecan—colon cancer	0.000283	0.00118	CcSEcCtD
Zoledronate—Shock—Capecitabine—colon cancer	0.000282	0.00117	CcSEcCtD
Zoledronate—Nervous system disorder—Capecitabine—colon cancer	0.000281	0.00117	CcSEcCtD
Zoledronate—Eye disorder—Methotrexate—colon cancer	0.000281	0.00117	CcSEcCtD
Zoledronate—Diarrhoea—Fluorouracil—colon cancer	0.000281	0.00117	CcSEcCtD
Zoledronate—Thrombocytopenia—Capecitabine—colon cancer	0.000281	0.00117	CcSEcCtD
Zoledronate—Tachycardia—Capecitabine—colon cancer	0.00028	0.00116	CcSEcCtD
Zoledronate—Vomiting—Vincristine—colon cancer	0.00028	0.00116	CcSEcCtD
Zoledronate—Cardiac disorder—Methotrexate—colon cancer	0.000279	0.00116	CcSEcCtD
Zoledronate—Skin disorder—Capecitabine—colon cancer	0.000279	0.00116	CcSEcCtD
Zoledronate—Rash—Vincristine—colon cancer	0.000277	0.00115	CcSEcCtD
Zoledronate—Hyperhidrosis—Capecitabine—colon cancer	0.000277	0.00115	CcSEcCtD
Zoledronate—Dermatitis—Vincristine—colon cancer	0.000277	0.00115	CcSEcCtD
Zoledronate—Headache—Vincristine—colon cancer	0.000276	0.00114	CcSEcCtD
Zoledronate—Anorexia—Capecitabine—colon cancer	0.000273	0.00113	CcSEcCtD
Zoledronate—Angiopathy—Methotrexate—colon cancer	0.000273	0.00113	CcSEcCtD
Zoledronate—Vomiting—Irinotecan—colon cancer	0.000272	0.00113	CcSEcCtD
Zoledronate—Immune system disorder—Methotrexate—colon cancer	0.000271	0.00113	CcSEcCtD
Zoledronate—Dizziness—Fluorouracil—colon cancer	0.000271	0.00113	CcSEcCtD
Zoledronate—Mediastinal disorder—Methotrexate—colon cancer	0.000271	0.00112	CcSEcCtD
Zoledronate—Rash—Irinotecan—colon cancer	0.00027	0.00112	CcSEcCtD
Zoledronate—Dermatitis—Irinotecan—colon cancer	0.00027	0.00112	CcSEcCtD
Zoledronate—Chills—Methotrexate—colon cancer	0.00027	0.00112	CcSEcCtD
Zoledronate—Headache—Irinotecan—colon cancer	0.000268	0.00111	CcSEcCtD
Zoledronate—Hypotension—Capecitabine—colon cancer	0.000268	0.00111	CcSEcCtD
Zoledronate—Alopecia—Methotrexate—colon cancer	0.000266	0.0011	CcSEcCtD
Zoledronate—Mental disorder—Methotrexate—colon cancer	0.000263	0.00109	CcSEcCtD
Zoledronate—Erythema—Methotrexate—colon cancer	0.000262	0.00109	CcSEcCtD
Zoledronate—Malnutrition—Methotrexate—colon cancer	0.000262	0.00109	CcSEcCtD
Zoledronate—Nausea—Vincristine—colon cancer	0.000261	0.00108	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000261	0.00108	CcSEcCtD
Zoledronate—Vomiting—Fluorouracil—colon cancer	0.000261	0.00108	CcSEcCtD
Zoledronate—GGPS1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	0.000261	0.00166	CbGpPWpGaD
Zoledronate—Insomnia—Capecitabine—colon cancer	0.000259	0.00108	CcSEcCtD
Zoledronate—Rash—Fluorouracil—colon cancer	0.000259	0.00107	CcSEcCtD
Zoledronate—Dermatitis—Fluorouracil—colon cancer	0.000259	0.00107	CcSEcCtD
Zoledronate—Paraesthesia—Capecitabine—colon cancer	0.000258	0.00107	CcSEcCtD
Zoledronate—Headache—Fluorouracil—colon cancer	0.000257	0.00107	CcSEcCtD
Zoledronate—Dysgeusia—Methotrexate—colon cancer	0.000256	0.00106	CcSEcCtD
Zoledronate—Dyspnoea—Capecitabine—colon cancer	0.000256	0.00106	CcSEcCtD
Zoledronate—Nausea—Irinotecan—colon cancer	0.000255	0.00106	CcSEcCtD
Zoledronate—Back pain—Methotrexate—colon cancer	0.000253	0.00105	CcSEcCtD
Zoledronate—Dyspepsia—Capecitabine—colon cancer	0.000252	0.00105	CcSEcCtD
Zoledronate—Decreased appetite—Capecitabine—colon cancer	0.000249	0.00103	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Capecitabine—colon cancer	0.000248	0.00103	CcSEcCtD
Zoledronate—Fatigue—Capecitabine—colon cancer	0.000247	0.00103	CcSEcCtD
Zoledronate—Vision blurred—Methotrexate—colon cancer	0.000247	0.00102	CcSEcCtD
Zoledronate—Pain—Capecitabine—colon cancer	0.000245	0.00102	CcSEcCtD
Zoledronate—Constipation—Capecitabine—colon cancer	0.000245	0.00102	CcSEcCtD
Zoledronate—Nausea—Fluorouracil—colon cancer	0.000244	0.00101	CcSEcCtD
Zoledronate—Ill-defined disorder—Methotrexate—colon cancer	0.000243	0.00101	CcSEcCtD
Zoledronate—Anaemia—Methotrexate—colon cancer	0.000242	0.001	CcSEcCtD
Zoledronate—GGPS1—Metabolism—PPARG—colon cancer	0.00024	0.00152	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CHST5—colon cancer	0.000237	0.00151	CbGpPWpGaD
Zoledronate—ABCC1—Disease—LGR5—colon cancer	0.000237	0.00151	CbGpPWpGaD
Zoledronate—Feeling abnormal—Capecitabine—colon cancer	0.000236	0.000981	CcSEcCtD
Zoledronate—Malaise—Methotrexate—colon cancer	0.000236	0.000979	CcSEcCtD
Zoledronate—Vertigo—Methotrexate—colon cancer	0.000235	0.000976	CcSEcCtD
Zoledronate—Gastrointestinal pain—Capecitabine—colon cancer	0.000235	0.000973	CcSEcCtD
Zoledronate—Leukopenia—Methotrexate—colon cancer	0.000234	0.000972	CcSEcCtD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—PPARG—colon cancer	0.00023	0.00146	CbGpPWpGaD
Zoledronate—Cough—Methotrexate—colon cancer	0.000228	0.000948	CcSEcCtD
Zoledronate—Urticaria—Capecitabine—colon cancer	0.000228	0.000946	CcSEcCtD
Zoledronate—Abdominal pain—Capecitabine—colon cancer	0.000227	0.000941	CcSEcCtD
Zoledronate—Body temperature increased—Capecitabine—colon cancer	0.000227	0.000941	CcSEcCtD
Zoledronate—Convulsion—Methotrexate—colon cancer	0.000227	0.000941	CcSEcCtD
Zoledronate—Arthralgia—Methotrexate—colon cancer	0.000223	0.000924	CcSEcCtD
Zoledronate—Myalgia—Methotrexate—colon cancer	0.000223	0.000924	CcSEcCtD
Zoledronate—Chest pain—Methotrexate—colon cancer	0.000223	0.000924	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000221	0.000918	CcSEcCtD
Zoledronate—Discomfort—Methotrexate—colon cancer	0.00022	0.000913	CcSEcCtD
Zoledronate—Confusional state—Methotrexate—colon cancer	0.000215	0.000894	CcSEcCtD
Zoledronate—Anaphylactic shock—Methotrexate—colon cancer	0.000213	0.000886	CcSEcCtD
Zoledronate—Infection—Methotrexate—colon cancer	0.000212	0.00088	CcSEcCtD
Zoledronate—Hypersensitivity—Capecitabine—colon cancer	0.000211	0.000877	CcSEcCtD
Zoledronate—Nervous system disorder—Methotrexate—colon cancer	0.000209	0.000869	CcSEcCtD
Zoledronate—Thrombocytopenia—Methotrexate—colon cancer	0.000209	0.000868	CcSEcCtD
Zoledronate—Skin disorder—Methotrexate—colon cancer	0.000207	0.000861	CcSEcCtD
Zoledronate—Hyperhidrosis—Methotrexate—colon cancer	0.000206	0.000857	CcSEcCtD
Zoledronate—Asthenia—Capecitabine—colon cancer	0.000206	0.000854	CcSEcCtD
Zoledronate—Anorexia—Methotrexate—colon cancer	0.000203	0.000845	CcSEcCtD
Zoledronate—Pruritus—Capecitabine—colon cancer	0.000203	0.000842	CcSEcCtD
Zoledronate—Hypotension—Methotrexate—colon cancer	0.000199	0.000828	CcSEcCtD
Zoledronate—ABCC1—Metabolism—ODC1—colon cancer	0.000199	0.00126	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CHST5—colon cancer	0.000199	0.00126	CbGpPWpGaD
Zoledronate—Diarrhoea—Capecitabine—colon cancer	0.000196	0.000815	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000195	0.000807	CcSEcCtD
Zoledronate—Insomnia—Methotrexate—colon cancer	0.000193	0.000802	CcSEcCtD
Zoledronate—Paraesthesia—Methotrexate—colon cancer	0.000192	0.000796	CcSEcCtD
Zoledronate—Dyspnoea—Methotrexate—colon cancer	0.00019	0.00079	CcSEcCtD
Zoledronate—Somnolence—Methotrexate—colon cancer	0.00019	0.000788	CcSEcCtD
Zoledronate—Dizziness—Capecitabine—colon cancer	0.00019	0.000787	CcSEcCtD
Zoledronate—GGPS1—Metabolism—PTGS2—colon cancer	0.000189	0.0012	CbGpPWpGaD
Zoledronate—Dyspepsia—Methotrexate—colon cancer	0.000188	0.00078	CcSEcCtD
Zoledronate—Decreased appetite—Methotrexate—colon cancer	0.000186	0.00077	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Methotrexate—colon cancer	0.000184	0.000765	CcSEcCtD
Zoledronate—Fatigue—Methotrexate—colon cancer	0.000184	0.000764	CcSEcCtD
Zoledronate—Pain—Methotrexate—colon cancer	0.000183	0.000758	CcSEcCtD
Zoledronate—Vomiting—Capecitabine—colon cancer	0.000182	0.000757	CcSEcCtD
Zoledronate—Rash—Capecitabine—colon cancer	0.000181	0.000751	CcSEcCtD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	0.000181	0.00115	CbGpPWpGaD
Zoledronate—Dermatitis—Capecitabine—colon cancer	0.000181	0.00075	CcSEcCtD
Zoledronate—Headache—Capecitabine—colon cancer	0.00018	0.000746	CcSEcCtD
Zoledronate—Feeling abnormal—Methotrexate—colon cancer	0.000176	0.00073	CcSEcCtD
Zoledronate—Gastrointestinal pain—Methotrexate—colon cancer	0.000175	0.000725	CcSEcCtD
Zoledronate—ABCC1—Disease—AXIN2—colon cancer	0.00017	0.00108	CbGpPWpGaD
Zoledronate—Nausea—Capecitabine—colon cancer	0.00017	0.000707	CcSEcCtD
Zoledronate—Urticaria—Methotrexate—colon cancer	0.00017	0.000704	CcSEcCtD
Zoledronate—Body temperature increased—Methotrexate—colon cancer	0.000169	0.000701	CcSEcCtD
Zoledronate—Abdominal pain—Methotrexate—colon cancer	0.000169	0.000701	CcSEcCtD
Zoledronate—CA14—Metabolism—ABCB1—colon cancer	0.000168	0.00107	CbGpPWpGaD
Zoledronate—CA14—Metabolism—TYMS—colon cancer	0.000165	0.00105	CbGpPWpGaD
Zoledronate—Hypersensitivity—Methotrexate—colon cancer	0.000157	0.000653	CcSEcCtD
Zoledronate—GGPS1—Metabolism—EP300—colon cancer	0.000157	0.000997	CbGpPWpGaD
Zoledronate—Asthenia—Methotrexate—colon cancer	0.000153	0.000636	CcSEcCtD
Zoledronate—Pruritus—Methotrexate—colon cancer	0.000151	0.000627	CcSEcCtD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—EP300—colon cancer	0.00015	0.000956	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—ABCB1—colon cancer	0.000147	0.000935	CbGpPWpGaD
Zoledronate—Diarrhoea—Methotrexate—colon cancer	0.000146	0.000606	CcSEcCtD
Zoledronate—FDPS—Metabolism—TYMS—colon cancer	0.000144	0.000918	CbGpPWpGaD
Zoledronate—CA12—Metabolism—ABCB1—colon cancer	0.000142	0.000901	CbGpPWpGaD
Zoledronate—Dizziness—Methotrexate—colon cancer	0.000141	0.000586	CcSEcCtD
Zoledronate—CA12—Metabolism—TYMS—colon cancer	0.000139	0.000885	CbGpPWpGaD
Zoledronate—Vomiting—Methotrexate—colon cancer	0.000136	0.000563	CcSEcCtD
Zoledronate—Rash—Methotrexate—colon cancer	0.000135	0.000559	CcSEcCtD
Zoledronate—Dermatitis—Methotrexate—colon cancer	0.000134	0.000558	CcSEcCtD
Zoledronate—Headache—Methotrexate—colon cancer	0.000134	0.000555	CcSEcCtD
Zoledronate—Nausea—Methotrexate—colon cancer	0.000127	0.000526	CcSEcCtD
Zoledronate—CA14—Metabolism—PPARG—colon cancer	0.000117	0.000744	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—PIK3CA—colon cancer	0.000116	0.000737	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—ABCB1—colon cancer	0.000112	0.000712	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	0.000111	0.000707	CbGpPWpGaD
Zoledronate—CA2—Metabolism—ABCB1—colon cancer	0.000108	0.000689	CbGpPWpGaD
Zoledronate—CA2—Metabolism—TYMS—colon cancer	0.000107	0.000677	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PPARG—colon cancer	0.000102	0.00065	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PPARG—colon cancer	9.87e-05	0.000627	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—AKT1—colon cancer	9.48e-05	0.000602	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PTGS2—colon cancer	9.21e-05	0.000585	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	8.2e-05	0.000521	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PTGS2—colon cancer	8.05e-05	0.000512	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PTGS2—colon cancer	7.76e-05	0.000493	CbGpPWpGaD
Zoledronate—CA14—Metabolism—EP300—colon cancer	7.66e-05	0.000487	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PPARG—colon cancer	7.55e-05	0.00048	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—EP300—colon cancer	6.7e-05	0.000426	CbGpPWpGaD
Zoledronate—CA12—Metabolism—EP300—colon cancer	6.46e-05	0.00041	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	6.45e-05	0.00041	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PTGS2—colon cancer	5.94e-05	0.000377	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PIK3CA—colon cancer	5.67e-05	0.00036	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—EP300—colon cancer	5.37e-05	0.000341	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ABCB1—colon cancer	5.25e-05	0.000334	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—TYMS—colon cancer	5.16e-05	0.000328	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PIK3CA—colon cancer	4.95e-05	0.000315	CbGpPWpGaD
Zoledronate—CA2—Metabolism—EP300—colon cancer	4.94e-05	0.000314	CbGpPWpGaD
Zoledronate—ABCC1—Disease—FGFR3—colon cancer	4.92e-05	0.000313	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PIK3CA—colon cancer	4.78e-05	0.000304	CbGpPWpGaD
Zoledronate—CA14—Metabolism—AKT1—colon cancer	4.63e-05	0.000294	CbGpPWpGaD
Zoledronate—ABCC1—Disease—APC—colon cancer	4.52e-05	0.000287	CbGpPWpGaD
Zoledronate—ABCC1—Disease—BRAF—colon cancer	4.25e-05	0.00027	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—AKT1—colon cancer	4.05e-05	0.000257	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	3.97e-05	0.000252	CbGpPWpGaD
Zoledronate—CA12—Metabolism—AKT1—colon cancer	3.9e-05	0.000248	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PPARG—colon cancer	3.65e-05	0.000232	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PIK3CA—colon cancer	3.65e-05	0.000232	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PTGS2—colon cancer	3.43e-05	0.000218	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CTNNB1—colon cancer	3.07e-05	0.000195	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CDKN1A—colon cancer	3e-05	0.000191	CbGpPWpGaD
Zoledronate—CA2—Metabolism—AKT1—colon cancer	2.98e-05	0.00019	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PTGS2—colon cancer	2.87e-05	0.000183	CbGpPWpGaD
Zoledronate—ABCC1—Disease—EP300—colon cancer	2.85e-05	0.000181	CbGpPWpGaD
Zoledronate—ABCC1—Disease—SRC—colon cancer	2.77e-05	0.000176	CbGpPWpGaD
Zoledronate—ABCC1—Disease—NRAS—colon cancer	2.67e-05	0.00017	CbGpPWpGaD
Zoledronate—ABCC1—Disease—MYC—colon cancer	2.49e-05	0.000158	CbGpPWpGaD
Zoledronate—ABCC1—Disease—TGFB1—colon cancer	2.48e-05	0.000158	CbGpPWpGaD
Zoledronate—ABCC1—Disease—EGFR—colon cancer	2.43e-05	0.000155	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—EP300—colon cancer	2.39e-05	0.000152	CbGpPWpGaD
Zoledronate—ABCC1—Disease—KRAS—colon cancer	2.3e-05	0.000146	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PIK3CA—colon cancer	2.11e-05	0.000134	CbGpPWpGaD
Zoledronate—ABCC1—Disease—HRAS—colon cancer	1.95e-05	0.000124	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PIK3CA—colon cancer	1.77e-05	0.000112	CbGpPWpGaD
Zoledronate—ABCC1—Disease—AKT1—colon cancer	1.72e-05	0.00011	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—AKT1—colon cancer	1.44e-05	9.18e-05	CbGpPWpGaD
